{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:28:25Z","timestamp":1748892505924},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T00:00:00Z","timestamp":1271980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s12032-010-9532-1","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T14:27:46Z","timestamp":1271946466000},"page":"840-845","source":"Crossref","is-referenced-by-count":10,"title":["Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK\/T-cell lymphoma"],"prefix":"10.1007","volume":"28","author":[{"given":"Meng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunji","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongbin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanming","family":"Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,23]]},"reference":[{"key":"9532_CR1","first-page":"55","volume":"49","author":"A Altemani","year":"2002","unstructured":"Altemani A, et al. Characteristics of nasal T\/NK-cell lymphoma among Brazilians. Neoplasma. 2002;49:55\u201360.","journal-title":"Neoplasma"},{"key":"9532_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ijc.2910440112","volume":"44","author":"K Aozasa","year":"1989","unstructured":"Aozasa K, et al. Nation-wide study of lethal mid-line granuloma in Japan: frequencies of Wegener\u2019s granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer. 1989;44:63\u20136.","journal-title":"Int J Cancer"},{"key":"9532_CR3","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood.V81.10.2688.2688","volume":"81","author":"P Kanavaros","year":"1993","unstructured":"Kanavaros P, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81:2688\u201395.","journal-title":"Blood"},{"key":"9532_CR4","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835\u201349.","journal-title":"J Clin Oncol"},{"key":"9532_CR5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V87.4.1207.bloodjournal8741207","volume":"87","author":"ES Jaffe","year":"1996","unstructured":"Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood. 1996;87:1207\u201310.","journal-title":"Blood"},{"key":"9532_CR6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","volume":"100","author":"CC Li","year":"2004","unstructured":"Li CC, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/T-cell or T-cell lymphoma. Cancer. 2004;100:366\u201375.","journal-title":"Cancer"},{"key":"9532_CR7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim CS, et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood. 2004;103:216\u201321.","journal-title":"Blood"},{"key":"9532_CR8","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/sj.leu.2403955","volume":"19","author":"YL Kwong","year":"2005","unstructured":"Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005;19:2186\u201394.","journal-title":"Leukemia"},{"key":"9532_CR9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","volume":"15","author":"JY You","year":"2004","unstructured":"You JY, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol. 2004;15:618\u201325.","journal-title":"Ann Oncol"},{"key":"9532_CR10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdn542","volume":"20","author":"A Jaccard","year":"2009","unstructured":"Jaccard A, et al. l-asparaginase-based treatment of 15 western patients with extranodal NK\/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol. 2009;20:110\u20136.","journal-title":"Ann Oncol"},{"key":"9532_CR11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1349-7006.2008.00768.x","volume":"99","author":"M Yamaguchi","year":"2008","unstructured":"Yamaguchi M, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia. Cancer Sci. 2008;99:1016\u201320.","journal-title":"Cancer Sci"},{"key":"9532_CR12","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.bbmt.2008.09.014","volume":"14","author":"J Lee","year":"2008","unstructured":"Lee J, et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer\/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant. 2008;14:1356\u201364.","journal-title":"Biol Blood Marrow Transplant"},{"key":"9532_CR13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdg458","volume":"14","author":"WY Au","year":"2003","unstructured":"Au WY, et al. Autologous stem cell transplantation for nasal NK\/T-cell lymphoma: a progress report on its value. Ann Oncol. 2003;14:1673\u20136.","journal-title":"Ann Oncol"},{"key":"9532_CR14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bmt.1705349","volume":"37","author":"HJ Kim","year":"2006","unstructured":"Kim HJ, et al. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK\/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplant. 2006;37:819\u201324.","journal-title":"Bone Marrow Transplant"},{"key":"9532_CR15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bbmt.2008.04.004","volume":"14","author":"AI Chen","year":"2008","unstructured":"Chen AI, et al. Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience. Biol Blood Marrow Transplant. 2008;14:741\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"9532_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.0902-4441.2003.00170.x","volume":"72","author":"K Koizumi","year":"2004","unstructured":"Koizumi K, et al. Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK\/T-cell lymphoma. Eur J Haematol. 2004;72:140\u20134.","journal-title":"Eur J Haematol"},{"key":"9532_CR17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05651.x","volume":"130","author":"N Murashige","year":"2005","unstructured":"Murashige N, et al. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol. 2005;130:561\u20137.","journal-title":"Br J Haematol"},{"key":"9532_CR18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF02982726","volume":"76","author":"M Makita","year":"2002","unstructured":"Makita M, et al. Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions. Int J Hematol. 2002;76:94\u20137.","journal-title":"Int J Hematol"},{"key":"9532_CR19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1704161","volume":"32","author":"T Yagi","year":"2003","unstructured":"Yagi T, et al. Esophageal actinomycosis after allogeneic peripheral blood stem cell transplantation for extranodal natural killer\/T cell lymphoma, nasal type. Bone Marrow Transplant. 2003;32:451\u20133.","journal-title":"Bone Marrow Transplant"},{"key":"9532_CR20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1620\/tjem.211.395","volume":"211","author":"H Yokoyama","year":"2007","unstructured":"Yokoyama H, et al. Successful treatment of advanced extranodal NK\/T cell lymphoma with unrelated cord blood transplantation. Tohoku J Exp Med. 2007;211:395\u20139.","journal-title":"Tohoku J Exp Med"},{"key":"9532_CR21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbmt.2003.09.015","volume":"10","author":"JM Vose","year":"2004","unstructured":"Vose JM, et al. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biol Blood Marrow Transplant. 2004;10:116\u201327.","journal-title":"Biol Blood Marrow Transplant"},{"key":"9532_CR22","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813\u201326.","journal-title":"N Engl J Med"},{"key":"9532_CR23","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1200\/JCO.1997.15.4.1595","volume":"15","author":"E Vandenberghe","year":"1997","unstructured":"Vandenberghe E, et al. Role of a second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry. J Clin Oncol. 1997;15:1595\u2013600.","journal-title":"J Clin Oncol"},{"key":"9532_CR24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bbmt.2008.05.021","volume":"14","author":"SM Smith","year":"2008","unstructured":"Smith SM, et al. Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. Biol Blood Marrow Transplant. 2008;14:904\u201312.","journal-title":"Biol Blood Marrow Transplant"},{"key":"9532_CR25","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1182\/blood-2004-01-0231","volume":"104","author":"CO Freytes","year":"2004","unstructured":"Freytes CO, et al. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. Blood. 2004;104:3797\u2013803.","journal-title":"Blood"},{"key":"9532_CR26","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1200\/JCO.2004.09.092","volume":"22","author":"MP Escalon","year":"2004","unstructured":"Escalon MP, et al. Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin\u2019s lymphoma whose disease has failed a prior autologous transplantation. J Clin Oncol. 2004;22:2419\u201323.","journal-title":"J Clin Oncol"},{"key":"9532_CR27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.bmt.1704942","volume":"35","author":"P Anderlini","year":"2005","unstructured":"Anderlini P, et al. Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin\u2019s disease: low transplant-related mortality and impact of intensity of conditioning regimen. Bone Marrow Transplant. 2005;35:943\u201351.","journal-title":"Bone Marrow Transplant"},{"key":"9532_CR28","first-page":"75","volume":"71","author":"M Sasaki","year":"2000","unstructured":"Sasaki M, et al. Successful treatment of disseminated nasal NK\/T-cell lymphoma using double autologous peripheral blood stem cell transplantation. Int J Hematol. 2000;71:75\u20138.","journal-title":"Int J Hematol"},{"key":"9532_CR29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbmt.2007.04.013","volume":"14","author":"AJ Bloor","year":"2008","unstructured":"Bloor AJ, et al. High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma. Biol Blood Marrow Transplant. 2008;14:50\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"9532_CR30","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol. 1988;6:1562\u20138.","journal-title":"J Clin Oncol"},{"key":"9532_CR31","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1080\/10428190127500","volume":"42","author":"K Takenaka","year":"2001","unstructured":"Takenaka K, et al. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas. Leuk Lymphoma. 2001;42:1297\u2013303.","journal-title":"Leuk Lymphoma"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-010-9532-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9532-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T23:33:57Z","timestamp":1591227237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-010-9532-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,23]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["9532"],"URL":"https:\/\/doi.org\/10.1007\/s12032-010-9532-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,23]]}}}